methoxy-morpholinyl-doxorubicin has been researched along with Heart Diseases in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Alam, A; Anne Hall, S; Michelle McKean, S; Patel, R; Paul Milligan, G; Van Zyl, J | 1 |
Agen, C; Danesi, R; Del Tacca, M; Di Paolo, A; Innocenti, F; Nardini, D; Pinna, A | 1 |
2 other study(ies) available for methoxy-morpholinyl-doxorubicin and Heart Diseases
Article | Year |
---|---|
Evolving the surveillance and workup of heart transplant rejection: A real-world analysis of the Molecular Microscope Diagnostic System.
Topics: Adult; Antibodies; Cell-Free Nucleic Acids; Doxorubicin; Graft Rejection; Heart Diseases; Heart Transplantation; Humans; Kidney Transplantation; Postoperative Complications; Retrospective Studies; RNA | 2022 |
Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.
Topics: Analysis of Variance; Animals; Doxorubicin; Electrocardiography; Female; Heart; Heart Diseases; Hemodynamics; Humans; Rats; Rats, Wistar; Tumor Cells, Cultured | 1994 |